In conjunction with the voluntary exchange offer of Mead Johnson Nutrition Company (USA) by Bristol-Myers Squibb Company (USA, GEIS Large Cap constituent), FTSE will apply any resulting index weighting changes as follows.
Subject to the results of the voluntary exchange offer which is set to expire 12:00 midnight New York City time, on 17 December 2009 unless extended or terminated, FTSE will issue a notification detailing any change in the number of Bristol-Myers Squibb shares in the index in relation to this voluntary exchange offer.
In line with the FTSE Global Equity Index Series ground rules, Mead Johnson Nutrition will not be considered for inclusion in the FTSE GEIS Index Series at this time.
FREE TRIAL OFFER: FTSE offers free one month index trials to interested clients. For further information or general enquiries please contact us at firstname.lastname@example.org or call:
|Client Services in UK:||Tel: +44 (0) 20 7866 1810|
|Client Services in Europe, Middle East & Africa:||Tel: +44 (0) 20 7866 1810|
|Client Services in US:||New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139|
|Client Services in Asia Pacific:||Tel: +852 2230 5803 or +65 6223 3738 or +81 3 3581 2811|
Alternatively please visit our website at www.ftse.com